( NASDAQ-NMS:BSTC )

News from biospecifics technologies corp A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Jun 13, 2016, 07:30 ET BioSpecifics Technologies Corp. Announces Positive Top-Line Results from Phase 2 Trial of CCH for Treatment of Human Lipoma

 BioSpecifics Technologies Corp. (NASDAQ: BSTC) today announced positive, statistically significant top-line results from a placebo-controlled,...


Jun 02, 2016, 07:30 ET BioSpecifics Technologies Corp. to Present at the Jefferies 2016 Healthcare Conference

 BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company that originated and continues to develop collagenase...


May 31, 2016, 07:30 ET BioSpecifics Technologies Corp. Announces Publication of Encouraging Data for Uterine Fibroid Treatment with CCH in American Journal of Obstetrics & Gynecology

BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company that originated and continues to develop collagenase based-therapies...


May 18, 2016, 07:30 ET BioSpecifics Technologies Corp. to Present at the 2016 UBS Global Healthcare Conference

 BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company that originated and continues to develop collagenase...


May 10, 2016, 07:30 ET BioSpecifics Technologies Corp. Reports First Quarter 2016 Financial Results

 BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company that originated and continues to develop collagenase...


May 03, 2016, 08:00 ET BioSpecifics Technologies Corp. to Report First Quarter 2016 Financial Results on Tuesday, May 10, 2016

BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company that originated and continues to develop collagenase based-therapies...


Apr 06, 2016, 08:00 ET BioSpecifics Technologies Corp. to Present at the 15th Annual Needham Healthcare Conference

 BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company that originated and continues to develop collagenase-based...


Mar 14, 2016, 07:00 ET BioSpecifics Technologies Corp. Reports Fourth Quarter and Full Year 2015 Financial Results

 BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company that originated and continues to develop collagenase...


Mar 08, 2016, 08:00 ET BioSpecifics Technologies Corp. to Present at the 28th Annual ROTH Conference

 BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company that originated and continues to develop collagenase...


Mar 07, 2016, 08:00 ET BioSpecifics Technologies Corp. to Report Fourth Quarter and Full Year 2015 Financial Results on Monday, March 14, 2016

 BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company that originated and continues to develop collagenase-based...


Feb 01, 2016, 08:00 ET BioSpecifics Technologies Corp. to Present at the 2016 BIO CEO & Investor Conference

BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company that originated and continues to develop collagenase based-therapies...


Jan 12, 2016, 17:00 ET BioSpecifics Technologies Corp. to Present at the Noble Financial Capital Markets' NobleCon12

 BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company that originated and continues to develop collagenase...


Nov 16, 2015, 08:00 ET BioSpecifics Technologies Corp. to Present at the Stifel 2015 Healthcare Conference

 BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company that originated and continues to develop collagenase...


Nov 09, 2015, 07:30 ET BioSpecifics Technologies Corp. Reports Third Quarter 2015 Financial Results

 BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company that originated and continues to develop collagenase...


Nov 05, 2015, 16:15 ET BioSpecifics Technologies Corp. Announces Partner Endo International Exercises Early Opt-In for XIAFLEX for Two New Indications

BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company that originated and continues to develop collagenase based-therapies...


Nov 02, 2015, 08:00 ET BioSpecifics Technologies Corp. to Report Third Quarter 2015 Financial Results on Monday, November 9, 2015

 BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company that originated and continues to develop collagenase...


Sep 21, 2015, 08:00 ET BioSpecifics Technologies Corp. Announces First Commercial Sale of XIAFLEX® for the Treatment of Dupuytren's Contracture in Japan

 BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company that originated and continues to develop collagenase...


Sep 02, 2015, 08:00 ET BioSpecifics Technologies Corp. Announces Presentations at Upcoming Investor Conferences

 BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company that originated and continues to develop collagenase...


Aug 31, 2015, 08:42 ET BioSpecifics Technologies Corp. Announces Formal Pricing of XIAFLEX® for the Treatment of Dupuytren's Contracture in Japan

BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company that originated and continues to develop collagenase based-therapies...


Aug 17, 2015, 16:51 ET BioSpecifics Technologies Corp. Announces Board Authorization of up to $2.5 Million Stock Repurchase Program

BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company that originated and continues to develop collagenase based-therapies...


Aug 10, 2015, 16:01 ET BioSpecifics Technologies Corp. Reports Second Quarter 2015 Financial Results

BioSpecifics Technologies Corp. (NASDAQ: BSTC) ("BioSpecifics" or the "Company"), a biopharmaceutical company that originated and continues to...


Aug 04, 2015, 07:00 ET BioSpecifics Technologies Corp. to Report Second Quarter 2015 Financial Results on Monday, August 10, 2015

 BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company developing first in class collagenase-based products marketed as...


Jul 20, 2015, 08:00 ET BioSpecifics Announces Approval of XIAFLEX® in Japan for the Treatment of Dupuytren's Contracture

 BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company developing first in class collagenase-based products, announced...


May 26, 2015, 08:30 ET BioSpecifics Technologies Corp. to Present at the Jefferies 2015 Healthcare Conference

BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company developing first in class collagenase-based products marketed as...


May 19, 2015, 16:08 ET BioSpecifics Reports Presentation of First Ever Treatment Guidelines for Peyronie's Disease and XIAFLEX Efficacy Data at AUA 2015 Annual Meeting

 BioSpecifics Technologies Corp. (NASDAQ: BSTC) ("BioSpecifics" or the "Company"), a biopharmaceutical company developing first in class...